TSHA
#2040
Taysha Gene Therapies, Inc. - Common Stock
5.7 0 USD
0.00%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+0.18%
Changement Mensuel
-3.23%
Evolution sur 6 mois
+26.95%
Changement Annuel
+100.70%
Clôture Précédente
5.6 9
Open
5.7 0
Low
5.7 0
High
5.7 0
Volume
94
Financials
- Market Capitalization 1.86 B
- Employee 99
- Founded 2019
- CEO N/A
- Website www.tayshagtx.com
- Headquarter Delaware, United States
- FIGI BBG00TJXFDP1
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-16.21
ratio cours/chiffre d'affaires
396.94
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2029 |  NBTX Nanobiotix S.A. - ADSs | 39.29 USD | -3.32% | -4.94% | +4.58% | +329.87% | 1.90 B USD | ||
| 2031 |  MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 7.30 USD | -4.45% | -17.51% | +10.61% | +211.97% | 1.90 B USD | ||
| 2047 |  INBX Inhibrx Biosciences, Inc. - Common Stock | 124.66 USD | -1.61% | +1.35% | +52.28% | +54.70% | 1.83 B USD | ||
| 2060 |  SNDX Syndax Pharmaceuticals, Inc. - Common Stock | 20.10 USD | +4.20% | +0.90% | +5.73% | +24.69% | 1.79 B USD |